Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3D Imaging is a specialized biotechnology company focused on the design, development, and production of radiopharmaceuticals for molecular imaging and targeted therapy. Headquartered in Little Rock, Arkansas, the company operates a state-of-the-art cyclotron facility and radiochemistry laboratories to support the creation of novel PET and SPECT imaging agents. Their business model encompasses internal drug discovery, clinical trial support, and contract manufacturing for pharmaceutical partners. 3D Imaging's expertise spans oncology and neurology, providing critical diagnostic tools for conditions such as prostate cancer and Alzheimer's disease. The company serves as a regional hub for the production and distribution of advanced medical isotopes and tracers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3D Imaging Drug Design and Development.